Management experience of a designated hospital for children with coronavirus disease 2019
ZHOU Jian-Guo1, FAN Qiao-Ling2, LU Chun-Mei1, XU Pu1, YAN Gang-Feng3, CHUNYU Ling-Feng4, LIU Ya-Zun5, CHEN Yi-Wei6, LU Yan-Ming7, ZHANG Ting8, YU Hui9, WANG Li-Bo10, XU Jiang-Jiang11, ZHOU Wen-Hao1
.Department of Neonatology, Children's Hospital of Fudan University, Shanghai 201102, China .Department of Infection Control, Shanghai Children's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200062, China
Abstract:The global pandemic of coronavirus disease 2019 (COVID-19) has brought great challenges to the traditional medical model. During the outbreak of COVID-19 in Shanghai, China, from March to May, 2022, there was a significant increase in the number of pediatric cases due to high transmissibility, immune escape, and vaccine breakthrough capacity of Omicron variants. The designated hospitals for children with COVID-19 served as a connecting link between children's specialized hospitals and mobile cabin hospitals. From April 7 to June 2, 2022, a total of 871 children with COVID-19 were admitted to Renji Hospital, Shanghai Jiao Tong University School of Medicine (South Branch), a designated hospital for children with COVID-19. Among these patients, 568 (65.2%) were children under 3 years old, 870 (99.9%) were mild or moderate, and 1 was severe. This article reports the experience in the management of pediatric cases in this designated hospital, which included the following aspects: establishing an optimal case-admission process; strengthening multidisciplinary standardized diagnosis and treatment; optimizing the management, warning, and rescue system for severe COVID-19; implementing family-centered nursing care; formulating an individualized traditional Chinese medicine treatment regimen; optimizing the discharge process and strengthening bed turnover; implementing strict whole-process control to reduce the risk of nosocomial infection; constructing a structured medical record system and using information platforms to adapt to the work mode of large-volume cases; conducting scientific research and sharing the experience in diagnosis and treatment.
ZHOU Jian-Guo,FAN Qiao-Ling,LU Chun-Mei et al. Management experience of a designated hospital for children with coronavirus disease 2019[J]. CJCP, 2022, 24(8): 839-845.
Dyer O. Covid-19: Omicron is causing more infections but fewer hospital admissions than delta, South African data show[J]. BMJ, 2021, 375: n3104. PMID: 34916213. DOI: 10.1136/bmj.n3104.
9 Yan G, Zhou J, Zhu H, et al. The feasibility, safety, and efficacy of Paxlovid treatment in SARS-CoV-2-infected children aged 6-14 years: a cohort study[J]. Ann Transl Med, 2022, 10(11): 619. DOI: 10.21037/atm-22-2791.